HOTH - 24/7 Market News Snapshot 13 Sept 2023

2023-09-13 10:18:38 ET

DENVER, Colo., Sept 13, 2023 ( www.247marketnews.com)-

News

Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease AND Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock – Rocket Pharma (NASDAQ: RCKT) is trading at $19.85, up $4.56 (+29.82%), on 4.91M, on 21.71M shares traded.

Workhorse Receives IRS Approval for Commercial Clean Vehicle Credit – Workhorse Group (NASDAQ: WKHS) is trading at $0.75, up $0.12 (+18.11%), on 11.28M, on 7.03M shares traded.

Hoth Therapeutics Announces Positive Results Killing Cancer Cells in Both Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia – Hoth Therapeutics (NASDAQ: HOTH) is trading at $3.01, up $0.33 (+12.31%), on 3.92M shares traded.

Mainz Biomed’s ColoFuture Study, Evaluating its Novel …

The post 24/7 Market News Snapshot 13 Sept 2023 appeared first on 24/7 Market News .

For further details see: